Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”
Gespeichert in:
Veröffentlicht in: | Clinical drug investigation 2023, Vol.43 (1), p.83-84 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 84 |
---|---|
container_issue | 1 |
container_start_page | 83 |
container_title | Clinical drug investigation |
container_volume | 43 |
creator | Grossi, Julia Diniz Surjan, Juliana Delfino, Rodrigo Simonini Del Porto, Jose Alberto Lacerda, Acioly Luiz Tavares |
description | |
doi_str_mv | 10.1007/s40261-022-01223-w |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2740509608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2740509608</sourcerecordid><originalsourceid>FETCH-LOGICAL-c228t-bf2c71b5135796d404ffdf8768143b3a334630bd727ad13d38ff404435356a813</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSMEoj_wAiyQl2xS_BcnsyzToSAVIbVlbTnxNfWQ2MF2qGY3r1EJXoDHmifBnZSyY3WvdL5zrq5OUbwi-IRgXL-NHFNBSkxpiQmlrLx9UhwSUi9KsiDN0_3OSloJdlAcxbjGmAgi6PPigAnOOKv5YfH7dEo3PsTd9g5dQhy9i4CSR0s_DOAS8g7ttj9XxthOdRuknEZXykDaIG_Q1dR2U1IO_BTRKn6DpAbrAFmH0g2g6wAqzSn3rO2sVr3N1qx_Umsf0BmMAWK0PwCd2eiDhrA_8c6Ovlf_dO92218vimdG9RFePszj4sv71fXyQ3nx-fzj8vSi7ChtUtka2tWkrQir6oXQHHNjtGlq0RDOWqYY44LhVte0VpowzRpjMsRZxSqhGsKOizdz7hj89wlikoONHfT9_KikNccVXgjcZJTOaBd8jAGMHIMdVNhIguV9R3LuSOaO5L4jeZtNrx_yp3YA_Wj5W0oG2AzELLmvEOTaT8Hln_8X-wdAL6Hz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2740509608</pqid></control><display><type>article</type><title>Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Grossi, Julia Diniz ; Surjan, Juliana ; Delfino, Rodrigo Simonini ; Del Porto, Jose Alberto ; Lacerda, Acioly Luiz Tavares</creator><creatorcontrib>Grossi, Julia Diniz ; Surjan, Juliana ; Delfino, Rodrigo Simonini ; Del Porto, Jose Alberto ; Lacerda, Acioly Luiz Tavares</creatorcontrib><identifier>ISSN: 1173-2563</identifier><identifier>EISSN: 1179-1918</identifier><identifier>DOI: 10.1007/s40261-022-01223-w</identifier><identifier>PMID: 36434374</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Bipolar Disorder - drug therapy ; Depressive Disorder, Major - drug therapy ; Humans ; Internal Medicine ; Ketamine - adverse effects ; Letter to the Editor ; Medicine ; Medicine & Public Health ; Pharmacology/Toxicology ; Pharmacotherapy ; Suicide</subject><ispartof>Clinical drug investigation, 2023, Vol.43 (1), p.83-84</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c228t-bf2c71b5135796d404ffdf8768143b3a334630bd727ad13d38ff404435356a813</cites><orcidid>0000-0002-9370-0449</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40261-022-01223-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40261-022-01223-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36434374$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grossi, Julia Diniz</creatorcontrib><creatorcontrib>Surjan, Juliana</creatorcontrib><creatorcontrib>Delfino, Rodrigo Simonini</creatorcontrib><creatorcontrib>Del Porto, Jose Alberto</creatorcontrib><creatorcontrib>Lacerda, Acioly Luiz Tavares</creatorcontrib><title>Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”</title><title>Clinical drug investigation</title><addtitle>Clin Drug Investig</addtitle><addtitle>Clin Drug Investig</addtitle><subject>Bipolar Disorder - drug therapy</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Ketamine - adverse effects</subject><subject>Letter to the Editor</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><subject>Suicide</subject><issn>1173-2563</issn><issn>1179-1918</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhSMEoj_wAiyQl2xS_BcnsyzToSAVIbVlbTnxNfWQ2MF2qGY3r1EJXoDHmifBnZSyY3WvdL5zrq5OUbwi-IRgXL-NHFNBSkxpiQmlrLx9UhwSUi9KsiDN0_3OSloJdlAcxbjGmAgi6PPigAnOOKv5YfH7dEo3PsTd9g5dQhy9i4CSR0s_DOAS8g7ttj9XxthOdRuknEZXykDaIG_Q1dR2U1IO_BTRKn6DpAbrAFmH0g2g6wAqzSn3rO2sVr3N1qx_Umsf0BmMAWK0PwCd2eiDhrA_8c6Ovlf_dO92218vimdG9RFePszj4sv71fXyQ3nx-fzj8vSi7ChtUtka2tWkrQir6oXQHHNjtGlq0RDOWqYY44LhVte0VpowzRpjMsRZxSqhGsKOizdz7hj89wlikoONHfT9_KikNccVXgjcZJTOaBd8jAGMHIMdVNhIguV9R3LuSOaO5L4jeZtNrx_yp3YA_Wj5W0oG2AzELLmvEOTaT8Hln_8X-wdAL6Hz</recordid><startdate>2023</startdate><enddate>2023</enddate><creator>Grossi, Julia Diniz</creator><creator>Surjan, Juliana</creator><creator>Delfino, Rodrigo Simonini</creator><creator>Del Porto, Jose Alberto</creator><creator>Lacerda, Acioly Luiz Tavares</creator><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9370-0449</orcidid></search><sort><creationdate>2023</creationdate><title>Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”</title><author>Grossi, Julia Diniz ; Surjan, Juliana ; Delfino, Rodrigo Simonini ; Del Porto, Jose Alberto ; Lacerda, Acioly Luiz Tavares</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c228t-bf2c71b5135796d404ffdf8768143b3a334630bd727ad13d38ff404435356a813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Bipolar Disorder - drug therapy</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Ketamine - adverse effects</topic><topic>Letter to the Editor</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><topic>Suicide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grossi, Julia Diniz</creatorcontrib><creatorcontrib>Surjan, Juliana</creatorcontrib><creatorcontrib>Delfino, Rodrigo Simonini</creatorcontrib><creatorcontrib>Del Porto, Jose Alberto</creatorcontrib><creatorcontrib>Lacerda, Acioly Luiz Tavares</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical drug investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grossi, Julia Diniz</au><au>Surjan, Juliana</au><au>Delfino, Rodrigo Simonini</au><au>Del Porto, Jose Alberto</au><au>Lacerda, Acioly Luiz Tavares</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”</atitle><jtitle>Clinical drug investigation</jtitle><stitle>Clin Drug Investig</stitle><addtitle>Clin Drug Investig</addtitle><date>2023</date><risdate>2023</risdate><volume>43</volume><issue>1</issue><spage>83</spage><epage>84</epage><pages>83-84</pages><issn>1173-2563</issn><eissn>1179-1918</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>36434374</pmid><doi>10.1007/s40261-022-01223-w</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-9370-0449</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1173-2563 |
ispartof | Clinical drug investigation, 2023, Vol.43 (1), p.83-84 |
issn | 1173-2563 1179-1918 |
language | eng |
recordid | cdi_proquest_miscellaneous_2740509608 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Bipolar Disorder - drug therapy Depressive Disorder, Major - drug therapy Humans Internal Medicine Ketamine - adverse effects Letter to the Editor Medicine Medicine & Public Health Pharmacology/Toxicology Pharmacotherapy Suicide |
title | Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression” |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T21%3A45%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Authors%E2%80%99%20Response%20to%20Comment%20on%20%E2%80%9CEfficacy%20and%20Safety%20of%20Subcutaneous%20Esketamine%20in%20the%20Treatment%20of%20Suicidality%20in%20Major%20Depressive%20Disorder%20and%20Bipolar%20Depression%E2%80%9D&rft.jtitle=Clinical%20drug%20investigation&rft.au=Grossi,%20Julia%20Diniz&rft.date=2023&rft.volume=43&rft.issue=1&rft.spage=83&rft.epage=84&rft.pages=83-84&rft.issn=1173-2563&rft.eissn=1179-1918&rft_id=info:doi/10.1007/s40261-022-01223-w&rft_dat=%3Cproquest_cross%3E2740509608%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2740509608&rft_id=info:pmid/36434374&rfr_iscdi=true |